Acrivon Therapeutics
ACRV
ACRV
48 hedge funds and large institutions have $109M invested in Acrivon Therapeutics in 2024 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 14 increasing their positions, 9 reducing their positions, and 5 closing their positions.
Holders
48
Holders Change
+7
Holders Change %
+17.07%
% of All Funds
0.7%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
12
Increased
14
Reduced
9
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
BlackRock
New York
|
$5.32M |
2 |
2
Renaissance Technologies
New York
|
$734K |
3 |
3
Millennium Management
New York
|
$683K |
4 |
4
Geode Capital Management
Boston,
Massachusetts
|
$1.74M |
5 |
BBA
5
Baker Bros. Advisors
New York
|
$378K |